ATR-IN-20

ATR-IN-20 is a highly potent dual inhibitor of ATM/ATR (IC50=3 nM) and mTOR (IC50=18 nM) with significant selectivity over related kinases. It demonstrates favorable oral bioavailability (F=30%) and exhibits promising anticancer activity in both cellular and animal models, supporting its use in DNA damage response and oncology research.